Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
McKinsey
Medtronic
Merck
McKesson

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Litigation Details for TEVA NEUROSCIENCE, INC. v. WATSON PHARMA, INC. (D.N.J. 2010)

See Plans and Pricing

« Back to Dashboard

TEVA NEUROSCIENCE, INC. v. WATSON PHARMA, INC. (D.N.J. 2010)

Docket   Start Trial Date Filed 2010-10-01
Court District Court, D. New Jersey Date Terminated 2014-09-26
Cause 35:145 Patent Infringement Assigned To Claire Claudia Cecchi
Jury Demand None Referred To William Clark
Parties APOTEX CORP.; APOTEX INC.; LAYN R. PHILLIPS; MYLAN INC.; MYLAN LLC.; MYLAN PHARMACEUTICALS, INC.; ORCHID CHEMICALS & PHARMACEUTICALS LTD.; ORCHID HEALTHCARE; ORGENUS PHARMA, INC.; TEVA NEUROSCIENCE, INC.; TEVA PHARMACEUTICALS INDUSTRIES, LTD.; TEVA PHARMACEUTICALS USA, INC.; WATSON LABORATORIES, INC.; WATSON PHARMA PRIVATE LTD. -UNIT IV; WATSON PHARMA, INC.; WATSON PHARMACEUTICAL INC.
Patents 5,453,446; 7,572,834
Attorneys ALLYN ZISSEL LITE; ARNOLD B. CALMANN; DAMIAN P. CONFORTI; GREGORY D. MILLER; INGRID ELISABETH DA COSTA; JASON B. LATTIMORE; KATHERINE ANN ESCANLAR; LAYN R. PHILLIPS; LOUIS JOHN DELJUIDICE; MICHAEL D. HALL; MICHAEL E. PATUNAS; NANCY ANN DEL PIZZO; SARAH CHRISTINE MITCHELL; SHEILA RAFTERY WIGGINS; SHILPA V. PATEL; VINCENT M. MEKLES
Firms Irell and Manella, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in TEVA NEUROSCIENCE, INC. v. WATSON PHARMA, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for TEVA NEUROSCIENCE, INC. v. WATSON PHARMA, INC. (D.N.J. 2010)

Date Filed Document No. Description Snippet Link To Document
2011-07-13 177 dismissing the parties' claims concerning U.S. Patent No. 7,572,834, w/prejudice. Signed by Judge Claire C. … 26 September 2014 2:10-cv-05078 830 Patent None District Court, D. New Jersey External link to document
2013-04-12 463 disputed terms in [nited States Patent No. 5,453.446 (“the ‘446 Patent”). A Markman hearing was held on…Factual Background United States Patent No. 5,453,446 claims a method of treating a patient with…understand a patent’s claim language, the Court must first look to the intrinsic record—the patent itself,…evidence of how the [Patent Trademark Office] and the inventor understood the patent.” Id. Further. the… (‘446 Patent, Abstract.) Indeed, the specification of the ‘446 Patent clearly distinguishes External link to document
2013-05-09 488 infringement of United States Patent No. 5,453,446 (“the ‘446 Patent”), which is alleged to cover Azilect…process, and unnecessary work for the trial court”); Patent Case Management Judicial Guide § 8.1.2.2.2.1 (Federal… 26 September 2014 2:10-cv-05078 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Boehringer Ingelheim
Harvard Business School
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.